A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains

Journal of Clinical Virology

Volumn 11, Issue 1, 1998, Pages 29-37

  Prix, L ^a   Maierl, J ^a   Jahn, G ^a   Hamprecht, K ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Drug resistance; Foscarnet; Ganciclovir; Human cytomegalovirus; Plaque assay

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CELL FREE SYSTEM; CYTOMEGALOVIRUS; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SCREENING; VIRUS CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; COCULTURE TECHNIQUES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, MICROBIAL; FOSCARNET; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; MICROBIAL SENSITIVITY TESTS; PLAQUE ASSAY;

EID: 0032563072     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(98)00043-9     Document Type: Article

References (22)

1. Alain S., Mazeron M., Pepin J., Morinet F., Raskine L., Sanson-LePors M. Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutations within the gene UL97. Mol Cell Probes. 7:1993;487-495.
2. Buchmeier N.A., Cooper N.R. Suppression of monocyte functions by human cytomegalovirus. Immunology. 66:1989;278-283.
3. Chou S., Erice A., Jordan M.C., Vercellotti G.M., Michels K.R., Talarico C.L., Stanat S.C., Biron K.K. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis. 171:1995;576-583.
4. Chou S., Guentzel S., Michels K.R., Miner R.C., Drew W.L. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis. 172:1995;239-242.
5. Crumpacker C.S. Drug resistance in cytomegalovirus: current knowledge and implications for patient managing. J Acquired Immune Defic Syndr. 12(Suppl 1):1996;S9-S16.
6. Dankner W.M., Scholl D., Stanat S.C., Martin M., Sonke R.L., Spector S.A. Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus. J Virol Methods. 28:1990;293-298.
7. Drew W.L., Miner R.C., Busch D.F., Follansbee S.E., Gullett J., Mehalko S.G., Gordon S.M., Owen W.F. Jr., Matthews T.R., Buhles W.C., DeArmond B. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 163:1991;716-719.
8. Drew W.L., Miner R., Saleh E. Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals. Clin Diagn Virol. 1:1993;179-185.
9. Gerna G., Baldanti F., Zavattoni M., Sarasini A., Percivalle E., Revello M.G. Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral Res. 19:1992;333-345.
10. Gerna G., Sarasini A., Percivalle E., Zavattoni M., Baldanti F., Revello M.G. Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. J Clin Microbiol. 33:1995;738-741.
11. Hanson M.N., Preheim L.C., Chou S., Talarico C.L., Biron K.K., Erice A. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother. 39:1995;1204-1205.
12. Knox K.K., Drobyski W.R., Carrigan D.R. Cytomegalovirus isolate resistant to gancicolovir and foscarnet from a marrow transplant patient. Lancet. 337:1991;1292-1293.
13. Lurain N.S., Ammons H.C., Kapell K.S., Yeldandi V.V., Garrity E.R., O'Keefe J.P. Molecular analysis of human cytomegalovirus strains from lung transplant recipients with the same donor. Transplantation. 62:1996;497-502.
14. Pepin J.M., Simon F., Dussault A., Collin G., Dazza M.C., Brun Vezinet F. Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J Clin Microbiol. 30:1992;2917-2920.
15. Rosen H.R., Benner K.G., Flora K.D., Rabkin J.M., Orloff S.L., Olyaei A., Chou S. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation. Transplantation. 63:1997;476-478.
16. Schrier R.D., Rice G.P.A., Oldstone M.B.A. Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis. 153:1986;1084-1091.
17. Slavin M.A., Bindra R.R., Gleaves C.A., Pettinger M.B., Bowden R.A. Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients. Antimicrob Agents Chemother. 37:1993;1360-1363.
18. Smith I.L., Shinkai M., Freeman W.R., Spector S.A. Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates. J Infect Dis. 173:1996;481-484.
19. Smith I., Cherrington J.M., Jiles R.E., Fuller M.D., Freeman W.R., Spector S.A. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase gene. J Infect Dis. 176:1997;69-77.
20. SOCA and ACTG cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. J Infect Dis. 176:1997;50-58.
21. Tatarowicz W.A., Lurain N.S., Thompson K.D. A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis. 166:1992;904-907.
22. Wolf D.G., Smith I.L., Lee D.J., Freeman W.R., Flores Aguilar M., Spector S.A. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest. 95:1995;257-263.